Purpose: To develop an Alcohol Withdrawal Syndrome (AWS) risk stratification tool that could support the safe discharge of low risk patients from the emergency department.
INTRODUCTION
Alcohol use is one of the major causes of disease, death and injury globally (World Health Organisation, 2014) . Excessive alcohol consumption is linked to over 200 physical and psychological diseases and has a longstanding association with cardiovascular disease, liver cirrhosis and various cancers (World Health Organisation, 2014; Holman et al., 1996) . From an acute health perspective the greatest impact of problematic alcohol use is witnessed by emergency departments, where at peak times 70% of attendances are alcohol related (Vardy et al., 2017; Waye et al., 2015; Stehman & Mycyk, 2013; Manasco. et al., 2012; Forsythe & Lee, 2012; The Department of Health, 2008) . The primary alcohol reason for hospital attendance is alcohol withdrawal syndrome (AWS) which is a risk in people who have alcohol dependence syndrome (ADS) when they stop drinking (Vardy et al., 2017) . ADS is recognised by the International Classification of Disease-Tenth Revision (ICD-10) when a person experiences three from a suite of six symptoms in the previous 12 months (World D r u g s a n d A l c o h o l T o d a y Benson 3 Scotland, 2017; NHS England, 2016; Maldonado et al., 2015; Pecoraro et al., 2013 : Dolman & Hawkes, 2005 .
The decision to admit to hospital for alcohol detoxification is not supported by the lack of a tool to inform physicians in this decision (Benson et al., 2019; NICE, 2016; Stephens et al., 2014; Repper-DeLisi et al., 2008) . Despite a number of retrospective studies investigating risk factors and SAWS, the only protocol located for the identification of low SAWS risk was developed by Stephens et al. (2014) . The Clinical Institute Withdrawal Assessment-Alcohol Revised (CIWA-AR) (Sullivan et al., 1989 ) was central to the Stephens et al. (2014) protocol where SAWS is suspected at a CIWA-AR > 15. While CIWA-AR > 15 necessitated inpatient detoxification, patients who had a CIWA-AR < 15 were screened for discharge (Stephens et al., 2014) .
Detoxification carried out in hospital is up to eight times more costly than outpatient treatment, and reduces the likelihood that patients will attend alcohol treatment programmes on hospital discharge (Alwyn et al., 2004; Cooper, 1995; Bartu & Saunders, 1994) . Importantly, outpatient detoxification presents comparable results with inpatient detoxification for patient abstinence, engagement, satisfaction and adverse events (Passeti et al., 2008) . However, the high incidence of alcohol presentations and subsequent admissions to hospital are having a detrimental impact on the NHS ability to achieve the Government's D r u g s a n d A l c o h o l T o d a y Benson 4 NHSGGC provides health care to a population of 1.2 million people and covers six of the most deprived post code areas in Scotland. Deprivation in Scotland is captured by the Statistical Index of Multiple Deprivation where 1 is the most deprived and 5 the least (ISD Scotland, 2017) . People living in the most deprived post code areas are eight times more likely to attend the emergency department for an alcohol related condition than people from more affluent areas (ISD Scotland, 2017; Walsh et al., 2010; The Scottish Government, 2009 ). In 2015/16 there were approximately 12,000 alcohol related acute hospital admissions in Glasgow (ISD Scotland, 2017) . Patients in NHSGGC admitted with an alcohol problem are referred to the acute addiction liaison nursing service (AALNS). The AALNS are a team of specialist nurses who provide assessment, treatment planning and onward referral for problematic alcohol use patients admitted to hospital (McPherson & Benson, 2011) . In NHSGGC, the level of a person's alcohol consumption and AWS symptoms are captured by the Glasgow Assessment Management of Alcohol (GAMA) guideline (McPherson et al., 2012) .
The GAMA is a comprehensive guideline that includes screening for alcohol use and dependency using the Fast Alcohol Screening Test (FAST) and a simple numeric score, the Glasgow Modified Alcohol Withdrawal Scale (GMAWS) to assess the symptoms of AWS (McPherson et al., 2012) . The original GAMA study (McPherson et al., 2012) like studies by Maldonado et al. (2015) , Pecoraro et al. (2013) and Dolman & Hawkes (2005) Benson 5 FAST have been validated and tested previously in the NHSGGC hospitals (McPherson et al., 2012) .
The aim of this study and described in this paper is to investigate whether the GMAWS and the quantitative variables identified through a systematic literature review (Benson et al., 2019) can be used in the emergency department to help stratifying a person's risk of developing SAWS and support clinicians in their decision to admit or not. The variables were; previous SAWS, ARS, DT`s, hours since last drink, age, post code, gender, reason for admission, physical observations, blood results, co-morbidities, and level of ADS. Currently only one study has explored the use of an alcohol risk stratification tool for the purpose of emergency department discharge (Stephens et al., 2014) . Because SAWS development is a consequence of years of drinking we employed a retrospective method, where risk measurement is time from data collection to analysis.
METHODS

Patients
Patients admitted acutely to the two large Glasgow acute adult hospitals within NHSGGC;
Queen Elizabeth University Hospital (QEUH) and Glasgow Royal Infirmary (GRI) through the emergency department and referred to the AALNS during one calendar month (1 st April -30 th April 2016) were retrospectively included in the study. This month was chosen because the study was part of a time limited project that coincided with the end of this period. All patients were treated using the GAMA guideline and benzodiazepines administered for AWS symptoms, and thiamine for treatment and prophylaxis of alcohol related brain damage. ADS Page 5 of 29  Drugs and Alcohol Today   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 was suspected at FAST ≥ 9 and confirmed using ICD-10 classification, while SAWS was recognised as GMAWS ≥ 4. Patients were only counted once and subsequent admissions excluded. We also excluded patients who had no documented ICD-10 classification and past or present alcohol history. Ethical approval was granted by the NHS West of Scotland
Research Ethics Committee (16/WS/0194).
Data collection
The medical records of the potential cohort for the study period were reviewed for exclusion criteria by a single investigator (AM) using a standard extraction form. The inclusion process is shown in Figure 1 . Four hundred and eighty nine records related to 432 patients, with only the first referral for patients retained. The first admission was used as this patient group are frequently admitted to hospital and in a number of occasions this may be recent, and therefore prior treatment could adversely impact on the patients presenting GMAWS. Of the 432 records only 400 had complete data, which also included ICD-10 classification of ADS. Next, a second investigator (GB) reviewed the records and recorded the variables of interest identified by the systematic literature review. The GMAWS measured the patients SAWS status (GMAWS 0-10) on attendance at the emergency department and during admission.
SAWS was reflective of GMAWS ≥ 4 and no SAWS, GMAWS < 4 and was supported by the total benzodiazepine requirement throughout admission. Any discrepancies were resolved by the wider research team. 
Data Analysis
Data was analysed using the Statistical Package for Social Scientists (SPSS) programme version 22. Spearman`s rank correlation coefficient was used to understand the unique contribution of the independent variables such as systolic blood pressure (SBP) on the dependent variable SAWS status (highest GMAWS). Additionally, as Spearman`s rank correlation coefficient does not make assumptions about the distribution of the data it was a test recommended when using an ordinal dependent variable such as GMAWS. Standard multiple linear regression and stepwise regression was employed to determine how the addition of each statistically significant variable (p= <0.05) contributed to the patients SAWS status during admission, while controlling for all others. Finally, as the aim of the study was to develop a tool to identify low risk of SAWS, there was a need to differentiate between SAWS (GMAWS ≥ 4) and no SAWS (GMAWS < 4). Therefore, binary logistic regression was performed on the variables to determine how effective they were in predicting the final SAWS status based on a dichotomised outcome of SAWS versus no SAWS. Binary logistic regression identified the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the variables that made the greatest contribution to the patients SAWS status during admission.
RESULTS
Cohort (n=400)
We collated the records from 400 patients, where 210 (53%) did not develop SAWS during their admission. Table 1 shows that the majority of patients were White Scottish (355/400) and the mean age of the cohort was 50 (± 12) years. The cohort was predominantly male (283 males, 117 females) and co-morbidity was recorded in 212 patient records and more prevalently recorded for patients who did not develop SAWS. Alcohol liver disease (ALD) was the most prominent (n=78) co-morbidity in the cohort and almost three quarters of patients lived in the two most deprived areas (n=337). The alcohol related conditions of AWS (n=190) and ARS (n=45) were the most common reason for admission and self-harm (n=29) the most non-alcohol related reason.
The mean FAST for the cohort was (14± 1.8) while over one third of the cohort records had a previous history of ARS recorded (n=138 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Benson 9 FAST (r = 0.243, N=398, p<0.01), GMAWS (r = 0.822, N=398, p<0.01) score at the emergency department, and hours since last drink (r = 0.548, N=398, p<0.01) were positively correlated with the SAWS status experienced during admission, while previous SAWS (r = -0.117, N=398, p<0.05) and ARS (r = -0.198, N=398, p<0.05) negatively correlated.
Spearman`s rank correlation identified that in isolation these variables were responsible for 1% (SAWS) to 68% (GMAWS) of the variance in a patients SAWS status during hospital admission.
The variables, hours since last drink, FAST, GMAWS at the emergency department, previous ARS, SAWS, ALT, AST, potassium, albumin, SBP, and pulse where analysed further using standard multiple linear regression. The standard multiple linear regression R value for the 11 variables above was strong (0.843) and accounted for an adjusted R² (squared) that explained 71% of the SAWS status experienced by patients during their hospital admission: F (11,396) = 72.83, p<0.001. However, using stepwise regression, seven of the variables were removed as they were not identified as predictor variables: ARS, SAWS, ALT, AST, potassium, albumin, and pulse. A significant model emerged that included: hours since last drink, FAST, GMAWS, and SBP, F (4,396) = 234.12, p<0.001. Table 2 shows that although the total R² adds up to 70%, its components are not unique, where fitting the selected predictors in a different order will result in different individual contribution to the same total R² outcome.
A logistic regression analysis was performed with SAWS status (SAWS = 0, no SAWS = 1) as the dependent variable and GMAWS at the emergency department, hours since last drink, FAST and SBP as predictor variables. A total of 400 cases were analysed and the total model significantly predicted SAWS status (omnibus chi-square= 316.68, df-4, p< 0.0005). The 
DISCUSSION
This retrospective cohort study was conducted to capture a population of patients who had a prevalent diagnosis of ADS and admitted to two large acute adult hospitals in Glasgow. A consequence of ADS is the development of AWS on cessation of alcohol use. AWS spans a spectrum that ranges from mild requiring minimal intervention to severe, where hospital admission and pharmacological treatment is required (Sutton & Juttel, 2016) . Although there are tools for the treatment of AWS, their purpose is for the identification and treatment of those at high risk of SAWS (Maldonado et al., 2015; Pecoraro et al., 2013; McPherson et al., 2012 : Dolman & Hawkes, 2005 . The studies investigating AWS identified that the emergency department was a good location to assess SAWS risk and commence treatment (Maldonado et al., 2015; Pecoraro et al., 2013; Eyer et al., 2011; Monte et al., 2010; Mennecier et al., 2008; Wright et al., 2006; Lee et al., 2005; Dolman & Hawkes, 2005; Lukan et al., 2002; Ferguson et al., 1996; Booth & Blow, 1993) . While we agree that the emergency department is an ideal location to identify risk, we looked at assessment as an opportunity to identify and discharge patients who had ADS and at low risk of SAWS.
Attendance at the emergency department with AWS is an ideal opportunity to develop a noninvasive measurement to stratify SAWS risk and discharge low risk patients home. From this study, a combination of GMAWS at the emergency department, FAST, hours since last drink and SBP appear to be a potential indicator of SAWS risk with sensitivity classification showing 84% accuracy in ruling out those without the disease, and 89% specificity ruling in those with the disease.
The results of our study are comparable with the studies by Maldonado et al. (2015) , Pecoraro et al. (2013) and Dolman and Hawkes (2005) , although these studies looked at risk stratification for hospital treatment. While the Maldonado et al. (2015) tool comprised of the 10 most common factors identified from their systematic literature review (Maldonado et al., 2014) , Goodson et al. (2014) in their meta-analysis of 15 studies found that only ARS and DT`s where statistically significant in SAWS risk in more than one study. The lack of consistent variables from studies investigating the same phenomenon suggests that the link with SAWS was either a chance association or a consequence of poor study design, execution or low prevalence. Moreover, although Pecoraro et al. (2013) and Dolman and Hawkes (2005) propose that the Alcohol Use Disorder Identification Test (AUDIT) was effective in identifying a person's risk of SAWS, this claim was not supported in other studies (Von-der- Pahlen Shevlin & Smith, 2007; Lima et al., 2005) . In contrast to our study these published risk stratification tools were based on positive results from small prevalence samples (7%; 1.4%; 2%) (Maldonado et al., 2015; Pecoraro et al., 2013; Dolman & Hawkes 2005) .
The one study by Stephens et al. (2014) that looked at low SAWS risk, unlike our study presented a limited systematic literature review that included only three studies. The key to the Stephens et al. (2014) process was the CIWA-AR and like the GMAWS presented scores for mild-moderate AWS and SAWS, where the mild to moderate patients were discharged home. Previous research has identified that discharge and successful engagement with alcohol care and treatment services through a home supported detoxification has been associated with a 59% reduction in emergency department attendances and 66% reduction in frequent hospital admissions (Tadros et al., 2013; Hughes et al., 2013) . However, the Stephens et al. (2014) process provided an outpatient detoxification that was unsupported. In addition, this process was guided by the CIWA-AR were the predictability for stratifying low SAWS risk was not investigated, and therefore risk of adverse events on discharge, unknown.
Consequently, the number of readmissions within the study population increased. For this reason and recognition that the variables in our tool were unable to guarantee no risk, an alternative to hospital admission in the form of a home supported detoxification for the population discharged from hospital would be explored.
In the AWS literature the importance of ADS appears to be overlooked, and presented as a (Maldonado et al., 2015; Pecoraro et al., 2013; Eyer et al., 2011; Monte et al., 2010; Mennecier et al., 2008; Wright et al., 2006; Lee et al., 2005; Dolman & Hawkes, 2005; Lukan et al., 2002; Ferguson et al., 1996; Booth & Blow, 1993) . However, like AWS, ADS spans a spectrum where SAWS risk is proportionate to a person's level of alcohol dependence (Stewart & Swain, 2012) . Therefore, as a determinant of SAWS the measure of ADS severity is paramount as a starting point to understanding risk (Stockwell et al., 1983) . Subsequently, none of the studies reviewed used a tool to record the severity of the persons ADS in an environment where poor alcohol assessment is known (Sutton & Juttel, 2016; Stehman & Mycyk, 2013; Forsythe & Lee, 2012) . Consequently, it is difficult to exclude the prospect that the results and low prevalence of ADS may be as reflective of the quality of assessment data as their association with SAWS risk.
Our study, unlike the AWS literature (Maldonado et al., 2015; Pecoraro et al., 2013; Eyer et al., 2011; Monte et al., 2010; Mennecier et al., 2008; Wright et al., 2006; Lee et al., 2005; Dolman & Hawkes, 2005; Lukan et al., 2002; Ferguson et al., 1996; Booth & Blow, 1993) , provided a population where the prevalence of ADS was high. The prevalence of ADS and use of FAST as a measure of ADS severity provided a population deemed high risk of SAWS. Consequently, the novel concept attributed to this study and not found in the literature is the development of a research based tool that can stratify a person's risk of developing SAWS and support clinicians in their decision to admit or discharge low risk patients from the emergency department.
The strengths of this study are the accuracy of the data collected by a specialist team of alcohol nurses. The retrospective nature of the study supported that GMAWS, FAST, hours (Maldonado et al. 2015; Eyer et al., 2011; Lee et al., 2005; Lukan et al., 2002; Ferguson et al., 1996) it is safe to assume that SAWS risk decreases with the increase of time (Munchie et al., 2013) . However, the impact of SBP is less clear in this population where high levels of co-morbidity and subsequent pharmacological treatment may have normalised an otherwise abnormal SBP (Chen et al., 2015) .
Despite the strengths of this study there are a number of limitations. First, the study was conducted in a single healthcare system that has a high prevalence of ADS, although the indicators within the tool are generalisable to other populations. Second, the original GAMA study (McPherson et al., 2012) presented high risk of SAWS at FAST ≥ 12, which may have resulted in some low risk patients receiving pharmacological intervention influencing their SAWS status. Finally, while the risk stratification tool had excellent predictability, the included variables were not fully responsible for the variance in whether the patient developed SAWS or not, and therefore an alternative treatment pathway is suggested in the form of a home supported detoxification.
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